Skip to main content
SpringerLink
Log in

Management of spasticity in multiple sclerosis by intrathecal baclofen

  • Chapter
Operative Neuromodulation

Part of the book series: Acta Neurochirurgica Supplements ((NEUROCHIRURGICA,volume 97/1))

Summary

Since its introduction, chronic intrathecal baclofen (ITB) infusion has been proved to improve spasticity, spasms and related pain. In the literature, the reported clinical improvement is evident in more than 85% of the patients suffering from spasticity and in more than 66% of the patients suffering from spasms. Usually, the evaluation of spasticity is carried out by the Asworth Scale although there is not yet general accordance on the validity of this scale. It is possible that some of the scales used to assess the implanted patients are not sensitive enough to detect changes in the quality of life or functional outcome. After the pump’s implantation, the overall care seems to be rather simple for a devoted team. The side effects are usually temporary but they can worry the patients. The most dangerous side effects are baclofen overdose and withdrawal syndrome. These complications are totally avoidable by adopting an approach attentive to the details regarding the patient, the device, and the procedure.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 189.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 249.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 329.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Akman MN, Loubser PG, Donovan WH (1993) Intrathecal baclofen: does tolerance occur? Paraplegia 31: 516–520

    PubMed  CAS  Google Scholar 

  2. Boviatsis EJ, Kouyialis AT, Korfias S, Sakas DE (2005) Functional outcome of intrathecal baclofen administration for severe spasticity. Clin Neurol Neurosurg 107: 289–295

    Article  PubMed  Google Scholar 

  3. Bramanti P, D’Aleo G, Rifici C, Alagna A, Cannata A, Sessa E, Di Bella P, Marra G (2004) Quality of life of patients with telemetric pumps for intrathecal baclofen infusion: data and limitations of assessment scales. Funct Neurol 19: 227–231

    PubMed  Google Scholar 

  4. Dario A, Scamoni C, Picano M, Fortini G, Cuffari S, Tomei G (2005) The infection risk of intrathecal drug infusion pumps after multiple refill procedures. Neuromodulation 8: 36–39

    Article  Google Scholar 

  5. Dario A, Tomei G (2004) A benefit-risk assessment of baclofen in severe spinal spasticity. Drug Saf 27: 799–818

    Article  PubMed  CAS  Google Scholar 

  6. Denys P, Mane M, Azouvi P (1998) Side effects of chronic intrathecal baclofen on erection and ejaculation in patients with spinal cord lesions. Arch Phys Med Rehabil 79: 494–496

    Article  PubMed  CAS  Google Scholar 

  7. Dressnandt J, Conrad B (1996) Lasting reduction of severe spasticity after ending chronic treatment with intrathecal baclofen. J Neurol Neurosurg Psychiatry 60: 168–173

    PubMed  CAS  Google Scholar 

  8. Francisco GE (2004) The role of intrathecal baclofen therapy in the upper motor neuron syndrome. Eura Medicophys 40: 131–143

    PubMed  CAS  Google Scholar 

  9. Gercek A, Baykan N, Dagcinar A, Ozek MM (2004) Does general anesthesia potentiate the GABA-ergic action of intrathecal baclofen? J Neurosurg Anesthesiol 16: 323–324

    Article  PubMed  Google Scholar 

  10. Hemingway C, McGrogan J, Freeman JM (2001) Energy requirements of spasticity. Dev Med Child Neurol 43: 277–278

    Article  PubMed  CAS  Google Scholar 

  11. Lehmann A, Mattsson JP, Edlund A, Johansson T, Ekstrand AJ (2003) Effects of repeated administration of baclofen to rats on GABAB receptor binding sites and subunit expression in the brain. Neurochem Res 28: 387–393

    Article  PubMed  CAS  Google Scholar 

  12. Levin ED, Weber E, Icenogle L (2004) Baclofen interactions with nicotine in rats: effects on memory. Pharmacol Biochem Behav 79: 343–348

    Article  PubMed  CAS  Google Scholar 

  13. Mertens P, Parise M, Garcia-Larrea L (1995) Long-term clinical, electrophysiological and urodynamic effects of chronic intrathecal baclofen infusion for treatment of spinal spasticity. Acta Neurochir Suppl 64: 17–25

    PubMed  CAS  Google Scholar 

  14. Middel B, Kuipers-Upmeijer H, Bouma J, Staal M, Oenema D, Postma T, Terpstra S, Stewart R (1997) Effect of intrathecal baclofen delivered by an implanted programmable pump on health related quality of life in patients with severe spasticity. J Neurol Neurosurg Psychiatry 63: 204–299

    PubMed  CAS  Google Scholar 

  15. Nielsen JF, Sinkjaer T (2004) Guided intrathecal baclofen administration by using soleus stretch reflex in moderate-severe spastic multiple sclerosis patients with implanted pump. Mult Scler 10: 521–525

    Article  PubMed  CAS  Google Scholar 

  16. Ordia JI, Fischer E, Adamski E, Chagnon KG, Spatz EL (2002) Continuous intrathecal baclofen infusion by a programmable pump in 131 consecutive patients with severe spasticity of spinal origin. Neuromodulation 5: 16–24

    Article  Google Scholar 

  17. Pandyan AD, Johnson GR, Price CI, Curless RH, Barnes MP, Rodgers H (1999) A review of the properties and limitations of the Ashworth and modified Ashworth scales as measures of spasticity. Clin Rehabil 13: 373–383

    Article  PubMed  CAS  Google Scholar 

  18. Penn RD (1992) Intrathecal baclofen for spasticity of spinal origin: seven years of experience. J Neurosurg 77: 236–240

    Article  PubMed  CAS  Google Scholar 

  19. Penn RD, Kroin JS (1985) Continuous intrathecal baclofen for severe spasticity. Lancet 2: 125–127

    Article  PubMed  CAS  Google Scholar 

  20. Plassat R, Perrouin Verbe B, Menei P, Menegalli D, Mathe JF, Richard I (2004) Treatment of spasticity with intrathecal baclofen administration: long-term follow-up, review of 40 patients. Spinal Cord 42: 686–693

    Article  PubMed  CAS  Google Scholar 

  21. Rizzo MA, Hadjimichael OC, Preiningerova J, Vollmer TL (2004) Prevalence and treatment of spasticity reported by multiple sclerosis patients. Mult Scler 10: 589–595

    Article  PubMed  CAS  Google Scholar 

  22. Schuele SU, Kellinghaus C, Shook SJ, Boulis N, Bethoux FA, Loddenkemper T (2005) Incidence of seizures in patients with multiple sclerosis treated with intrathecal baclofen. Neurology 64: 1086–1087

    PubMed  CAS  Google Scholar 

  23. Taha J, Favre J, Janszen M, Galarza M, Taha A (2004) Correlation between withdrawal symptoms and medication pump residual volume in patients with implantable SynchroMed pumps. Neurosurgery 55: 390–394

    Article  PubMed  Google Scholar 

  24. Tardieu G, Shentoub S, Delarue R (1954) Research on a technic for measurement of spasticity. Rev Neurol (Paris) 91: 143–144

    PubMed  CAS  Google Scholar 

  25. Zahavi A, Geertzen JH, Middel B, Staal M, Rietman JS (2004) Long term effect (more than five years) of intrathecal baclofen on impairment, disability, and quality of life in patients with severe spasticity of spinal origin. J Neurol Neurosurg Psychiatry 75: 1553–1557

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Clinica Neurochirurgica, Ospedale di Circolo e Fondazione Macchi Viale Borri, 57 - 21100, Varese, Italy

    Alessandro Dario

  2. Neurosurgical Clinic, Insubria University, Varese, Italy

    G. Tomei

Authors
  1. Alessandro Dario
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. G. Tomei
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Alessandro Dario .

Editor information

Editors and Affiliations

  1. Department of Neurosurgery, University of Athens, Athens, Greece

    Damianos E. Sakas

  2. University Hospital of Wales, Cardiff, UK

    Brian A. Simpson

  3. Pacific Pain Treatment Centers, San Francisco, USA

    Elliot S. Krames

Rights and permissions

Reprints and permissions

Copyright information

© 2007 Springer-Verlag

About this chapter

Cite this chapter

Dario, A., Tomei, G. (2007). Management of spasticity in multiple sclerosis by intrathecal baclofen. In: Sakas, D.E., Simpson, B.A., Krames, E.S. (eds) Operative Neuromodulation. Acta Neurochirurgica Supplements, vol 97/1. Springer, Vienna. https://doi.org/10.1007/978-3-211-33079-1_26

Download citation

  • DOI: https://doi.org/10.1007/978-3-211-33079-1_26

  • Publisher Name: Springer, Vienna

  • Print ISBN: 978-3-211-33078-4

  • Online ISBN: 978-3-211-33079-1

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation